TruthArchive.ai - Related Video Feed

The speaker raises concerns about the contamination of vaccines with plasmid DNA and questions the validity of the specified limit. They criticize the lack of testing and transparency by authorities and highlight reports of contamination in Germany. The speaker suggests that further investigation is needed to determine the potential negative effects of these contaminants. They emphasize the importance of clear communication, testing for adverse effects, and conducting prospective studies to assess any potential risks. The speaker also mentions that vaccines do not remain solely at the injection site but can reach various organs, including the liver, heart, and brain. They believe that people should be informed about these issues and the possible side effects.

The speakers discuss concerns about residual DNA in mRNA COVID-19 vaccines and the potential risks associated with the lipid nanoparticle delivery system. They question whether the FDA's standards for acceptable levels of residual DNA consider this delivery system and its potential to distribute DNA to unintended locations. They also mention anecdotal reports of menstrual cycle issues and miscarriages in women who have received the vaccine. The speakers criticize the FDA, CDC, and NIH for not thoroughly evaluating these risks and continuing to promote the vaccine without proper investigation. They predict that there will be consequences for the harm caused by the vaccines and express hope for future accountability.

This is a discussion about the Gardasil cervical cancer vaccine and a core issue believed to be at the heart of global legal actions, with a focus on contaminant DNA linked to the aluminum adjuvant and the evidence that emerged from studies conducted at that time. Speaker 0 explains that the vaccine, including Gardasil, has become the subject of surprising court cases worldwide, with large plaintiff groups in Japan composed largely of young women and girls. The central issue, according to the speaker, is the contamination of the D-N-E (DNA) in the vaccine, which has been the topic of concern since the early days, with the Ministry of Health, Labour and Welfare in Japan reportedly recognizing this as the core problem. In 2012, a paper made the DNA contamination issue very clear, showing that the HPV DNA fragments for HPV types 16, 18, 6, and others associated with the vaccine were found in the vaccine samples. The speaker notes that the Hepatitis B, HPV, and ERV (endogenous retrovirus) elements were involved in the analysis and that it was proposed that the DNA could bind to the aluminum adjuvant particles within the vaccine. The speaker mentions Shin Handei (Shin Han-ji) as an early voice raising alarms about the DNA contamination problem during the pandemic period, and that Kevin-sensei (Professor Kevin) referenced this work about a month earlier. The discussion highlights that doctors worldwide, listening to the voices of women and girls, observed that the same concerns about unusual adverse events after vaccination emerged globally. The claim is that residual HPV DNA from Gardasil was present in multiple samples and that the DNA, when tested, appeared to be identical in sequence to the described HPV DNA. The speaker states that eighteen types of samples were examined from countries including Australia, Bulgaria, France, India, New Zealand, Poland, Russia, Spain, and the United States. According to the account, 16 and 18 types were the primary concern, and the remaining DNA fragments were reported to be directly bound to aluminum adjuvant particles. The speaker cites that 16-part packages of Gardasil-4, when examined, contained residual HPV DNA fragments bound to aluminum adjuvant particles, and that the DNA sequences matched those identified by PCR. This was reported as having occurred in 2012. Subsequently, in 2014, the vaccine program in Japan was halted, with introduction on April 1st and cessation shortly thereafter due to the emerging concerns. In 2014, Shin Handi, Jerôme from France, and Dalma from the UK were noted as participants in a conference where the discussion continued, including claims that in 2014 the concern about residual HPV DNA led to stronger actions regarding testing and safety discussions. The dialogue then references broader regulatory contexts: a 2016 document indicating changing standards for DNA remnants (with WHO and FDA guidance) and the notion that DNA contamination thresholds were being adjusted—such as the threshold changing from 10 picograms to 100 times higher over the years, and later to roughly 10,000 picograms. The implication is that the fixed safety limits were evolving in a way that favored pharmaceutical manufacturers, with the argument that the changes in base values were not aligned with human biology, but rather with manufacturing practices. The speakers emphasize that in Japan, the issue of DNA contamination was broadcast worldwide, with researchers, journalists, and affected individuals all aware of the problem and the stakes involved, making Japan a central stage for these concerns. Speaker 1 adds that a year prior, it became clear that female safety and the DNA contamination issue were major questions in Japan, leading to discussions about stopping messenger-type vaccines and reconsidering RN-type vaccines, given the fatalities associated with those vaccine deployments, reinforcing opposition among certain groups. The exchange ends with a reaffirmation of concern about the continued risk and opposition.

Speaker 0 describes a highly significant and controversial issue surrounding human papillomavirus (HPV) vaccines, including Gardasil and Cervarix, and reports that lawsuits are occurring worldwide. In Japan, there have been major lawsuits with hundreds of plaintiffs, including young women and girls, though the fundamental problem, according to the speaker, centers on contamination with DNA impurities. The speaker states that from the early days of the Ministry of Health, Labour and Welfare in Japan, the core issue has been the contamination with DNA impurities in vaccines, and that this problem had already become clear by 2012 in a widely cited paper. The speaker explains that by 2012, a paper described the DNA contamination in Gardasil-related vaccines, specifically noting residual DNA fragments from HPV types 16 and 18 associated with the vaccine’s aluminum adjuvant particles. The claim is that vaccine samples contained residual HPV DNA fragments that were directly bound to aluminum adjuvant particles, and that PCR tests confirmed these DNA fragments were identical to the HPV sequences described in the paper. The speaker emphasizes that researchers around the world—doctors and researchers listening to women and girls’ voices—noticed unusual, severe post-vaccination symptoms in children and young women, and saw potential links between these symptoms and the residual HPV DNA attached to adjuvants. The testimony references samples gathered from multiple countries (Australia, Bulgaria, France, India, New Zealand, Poland, Russia, Spain, and the United States) and asserts that nearly all of the Gardasil/HPV vaccine lots examined contained residual HPV DNA attached to aluminum adjuvant particles. The speaker mentions that in the specific investigation, sixteen samples of Gardasil-4 contained residual HPV DNA fragments bound to aluminum adjuvant particles, and that all samples tested via PCR showed the same DNA sequence as described in the 2012 paper. The speaker claims that in 2014, the vaccine program for cervical cancer halted in Japan, and that the subsequent attention brought this issue to light publicly. The discussion attributes the major role to a Japanese expert, Ishii Ken (Ishii-sensei), described as a leading figure in Japan’s vaccine adverse-event research. The speaker recounts that, in the years around 2012–2014, efforts involved international collaboration with HR/HSA, FDA, and others, although logistical obstacles caused delays. The speaker notes that in 2012, 16 vaccine packages were distributed in nine countries for examination and that contamination persisted in all samples. They credit Japan with acting as a global relay for disseminating information about DNA contamination and its potential health implications. Further, the speaker references a broader context: the later emergence of literature discussing how DNA contamination might relate to adverse neurological or systemic symptoms, and the evolution of guidelines on acceptable residual DNA in vaccines. The discussion mentions that WHO and FDA guidelines permit changing permissible DNA limits over time, with higher thresholds introduced for manufacturing and regulatory purposes, raising questions about what constitutes safety and what is permissible in drug development. The dialogue closes with Speaker 1 alluding to the seriousness of the issue, noting deaths in the context of messenger-type vaccines and subsequent debates about vaccine safety, while acknowledging that those opposed to this view are also active.

The Pfizer and Moderna vaccines contain fragments of DNA, which can integrate into the genomic DNA of cells and become a permanent part of the cell. This poses a potential risk of autoimmune attacks and future cancer. The DNA contamination occurred during the production process, where a plasmid vector was used to scale up the production of the RNA template. The regulatory threshold for DNA in vaccines is outdated and not suitable for this new type of vaccine. The speaker believes that DNA sequencing should be done on vaccinated individuals' stem cells to determine if this theoretical risk has occurred. Informed consent is necessary, and the lack of transparency regarding the DNA contamination is concerning.

Mr. Kevin McKernan, a former leader at the Human Genome Project, discussed DNA contamination in Pfizer and Moderna vaccines. He highlighted the risks of insertional mutagenesis and integration into the genome, contradicting regulators' claims of little consequence. The DNA, found in lipid nanoparticles, can enter cells and potentially contribute to cancer. McKernan emphasized the inadequacy of current monitoring methods and called for a review of regulatory practices. The presence of DNA in these vaccines challenges existing safety standards and raises concerns about long-term effects.

The speaker raises concerns about the contamination of vaccines with plasmid DNA and questions the validity of the specified limit. They criticize the lack of testing and transparency by authorities and argue for further investigation into the potential negative effects of the contamination. The speaker suggests that clean communication, testing for adverse effects, and prospective studies differentiating between vaccinated and unvaccinated individuals are necessary. They also highlight that the vaccine does not remain solely at the injection site but spreads to various organs, potentially causing side effects. The speaker emphasizes the need for open discussion and awareness of these issues.

A biochemist and toxicologist discusses concerns about the Pfizer vaccine. They claim that the vaccine contains plasma DNA, including SV40 sequences, which were not disclosed to regulators. They believe this is intentional and could lead to DNA integration and potential cancer risks. The speaker argues that the DNA in the vaccine is different from RNA and can be permanent. They suggest that safer alternatives like hydroxychloroquine and ivermectin exist and question the transparency of the FDA. They urge states to protect their citizens and reconsider the use of the vaccine, especially for pregnant women and children.

Thank you, Senator Johnson. I want to address the DNA contamination found in Pfizer and Moderna mRNA vaccines, which has been confirmed by multiple labs and acknowledged by regulatory agencies like the FDA and EMA. They downplay the significance of this contamination, claiming it has no functional consequences, which is misleading. DNA contamination can lead to insertional mutagenesis, as noted in Moderna's patents. The contamination levels vary significantly between lots, and current measurement methods allow for selective reporting. We have evidence that this DNA can integrate into the genome, raising concerns about genotoxicity, especially given the rise in cancer drug sales since the vaccine rollout. Regulatory practices need to be reviewed, particularly the PDUFA Act, which allows regulators to accept funding from the companies they oversee, creating conflicts of interest. Informed consent processes have not addressed this contamination issue, yet mandates persist based on flawed regulatory guidance. Thank you.

The speaker claims that this is not conspiracy theory and cites a BMJ publication by Retzaf Levy, which describes a process in vaccine development: vaccines were trialed under one formulation, but when the decision was made to deploy them globally, the process was changed and the product injected to the rest of the world. The speaker asserts that changing the process requires new trials, yet the EMA asked for an additional trial of 250 people after the process change, and that data was never delivered. This is described as a “bait and switch,” asserted as crucial for understanding why trial data is of zero consequence to what’s seen in the field, implying that real-world outcomes do not match trial data and that the numbers from trials are a caricature of field performance. The speaker claims Pfizer had early data indicating what would happen and acted on that by acquiring cancer companies: $43,000,000,000 into the acquisition of C Gen and $2,260,000,000 to acquire Trillium Therapeutics. Trillium is described as focused on blood cancers with the CD147 marker (CD Adaptor 147) on them, a marker claimed to be known to be involved in COVID. The implication is that Pfizer is building an investment portfolio in cancer companies that would benefit from the consequences the speaker alleges they caused. In summary, the vaccines on the market are said to be not the same formulation as what was tested in clinical trials, labeling this a “bait and switch” and a fraud, and asserting that vaccine effectiveness numbers are not reliable because the products differ from trial formulations and because those numbers decay over time. The speaker alleges significant DNA contamination, stating that 10 out of 11 studies have found this, with the remaining studies allegedly constrained by financial conflicts. The claim is that consensus among real studies supports DNA contamination, with several studies through peer review, which the speaker notes is difficult for those papers to pass through peer review. It is claimed that five peer-reviewed studies not originally examining contamination found DNA in blood and tissue upon sleuthing. The speaker asserts that cancer is on the rise and that several papers report cancer post-vaccination, including neoplasms at the site of injection. The claim is that this situation cannot be dismissed as coincidence and is described as “liability free” and often mandated. The speaker posits that this may be the largest carcinogenic hit to the human population, with vaccines on childhood schedules and given to pregnant women, stating that “this has gone absolutely off the rails.”

The speaker discusses the issue of DNA contamination in mRNA COVID-19 vaccines and questions the FDA's handling of the situation. They explain that normally rigorous tests are required to ensure safety, but in this case, the FDA ignored those tests. The speaker also mentions that Moderna's own patent acknowledges concerns about DNA and insertional immunogenesis. They reveal that DNA fragments, including an antibiotic resistance gene and sequences from simian virus 40, were found in the vaccines. The speaker expresses shock at the FDA's lack of transparency and highlights the potential risks associated with DNA damage, such as cancer and birth defects.

The speaker discusses DNA contamination found in Pfizer and Moderna mRNA vaccines, highlighting regulatory agencies' failure to address the issue. They mention potential risks of DNA integration and cancer development, urging for a review of regulatory practices. Concerns are raised about DNA levels exceeding limits, potential cell integration, and long-term presence in the body. The speaker emphasizes the need for better monitoring tools and the unique nature of DNA contamination in these vaccines.

The speaker expresses concerns about the safety of COVID-19 vaccines, particularly regarding the presence of DNA and contamination in the shots. They argue that the vaccines have caused more deaths in a few months than all other vaccines combined in the past 30 years. The speaker also discusses the potential risks of gene therapy and the presence of SV40 sequences and antibiotic-resistant genes in the shots. They believe that the contamination and intentional inclusion of certain sequences raise concerns about the vaccines' safety. The speaker calls for the recall of the vaccines, especially for children, and questions the transparency of the FDA and CDC in handling the data. They suggest using alternative treatments like hydroxychloroquine and ivermectin.

The speaker expresses concern about the safety of COVID-19 vaccines, particularly regarding the presence of DNA and contamination in the shots. They argue that the number of deaths reported after the vaccine rollout is higher than in the past 30 years combined for all other vaccines. The speaker also discusses the risk of gene therapy and the potential for cancer and autoimmune reactions. They mention the presence of SV40 sequences and antibiotic-resistant genes in the shots, which they believe is intentional. The speaker highlights the increase in miscarriages and stillbirths reported after vaccination and questions the transparency of the FDA and CDC. They urge for the recall of the vaccines and express frustration with the lack of action taken.

The speaker discusses the contamination of vaccines with plasmid DNA and questions the validity of the specified limit of 10 nanograms per dose. They criticize the lack of thorough testing and communication by authorities regarding this issue. The speaker suggests that further investigations and prospective studies should be conducted to determine the potential risks and side effects of the vaccines. They also mention that the vaccine can spread beyond the injection site and reach various organs, including the liver, heart, and even the brain. The speaker emphasizes the importance of transparent communication and informed decision-making regarding vaccination.

In this video, the speakers discuss new information about the mRNA vaccines and the presence of DNA in them. Researchers have found that some mRNA vaccines contain DNA fragments, which can cause issues with gene expression and potentially increase the risk of cancer. The presence of DNA in the vaccines is a manufacturing problem, and it is unclear why it was included. The DNA can enter cells and interfere with important genes, leading to various health problems. The speakers emphasize the need to investigate the extent of DNA contamination in the vaccines and consider stopping their production until the issue is resolved.

The speaker discusses the presence of DNA in the Pfizer vaccine and expresses concern about its potential consequences. They explain that they sequenced the DNA in the vaccine and found it surprising that any DNA was present. The speaker suggests that this DNA could be causing rare but serious side effects, such as death from cardiac arrest. They also mention that the DNA could integrate into the genomic DNA of cells, potentially leading to genome modification and autoimmune attacks. There is a theoretical risk of future cancer as well. The speaker emphasizes the need to investigate these concerns further.

The speaker raises concerns about the contamination of current vaccines with DNA and the unknown consequences of this contamination. They argue that efforts should be made to eliminate DNA contamination, even if it increases production costs. The speaker mentions a researcher from MIT who accidentally discovered that mRNA vaccines were contaminated with DNA. They criticize Pfizer for testing vaccines from one process and then vaccinating billions of people with vaccines from another process, which were contaminated with DNA. The presence of DNA in the vaccines raises risks, including potential cancer development. The speaker believes it is misleading to claim that the vaccines have undergone clinical trials when they have not been properly studied. They call for more rigorous research before commercializing vaccines.

The speakers discuss the vaccination landscape around human papillomavirus (HPV) vaccines, focusing on a controversial issue they claim has been known and disseminated since early on: contamination with DNA (DNA residuals) from Deinococcus or related genetic material in vaccines and the implications of aluminum adjuvants used in Gardasil/Gardasil 9. - They begin by asserting that HPV vaccines, including Gardasil/Sil, have been the subject of remarkable legal actions worldwide, including four major lawsuits in Japan. They note that historically, in Japan, many young women and girls stood as plaintiffs, and that the core problem they highlight is the DNA contamination issue (referred to as “ディー エ ヌ エー 混 入 汚 染 問 題”). - The claim is that from early on, the Japanese Ministry of Health, Labour and Welfare and others acknowledged this contamination as central. They reference a 2012 paper that reportedly made the DNA contamination problem very clear, naming pathogens such as Human Papillomavirus, HPV, and DEIN? They describe that vaccine particles (HBV? HPBL DNA fragments) were found to be directly bound to aluminum adjuvant particles in Gardasil, implying a mechanism by which residual DNA could be involved in adverse effects. - The speakers say that the 2012 study, and subsequent work, led to attention from doctors worldwide who listened to the voices of women and girls and wondered what was happening with the vaccine recipients. They claim that samples showed that residual HPV DNA fragments were consistently present and directly linked to aluminum adjuvant particles, and that “PCR” detection indicated the same DNA sequences across samples. They mention that the 2012 paper’s findings were followed by reporting that, by 2014, vaccination had been suspended in Japan earlier than many would have expected. - They recount a process in which major scientists from various countries (France, the UK, and others) were involved in investigating adenoviral or genetic components (they reference Shihan? and others) and that the Japan-based researchers, including Ishii Ken, were central figures. They describe meetings, PowerPoint presentations at a hotel, and a sequence of visits to the UK and the US (including HR-related planning with U.S. FDA and the UK authorities) that were interrupted by closures in the Obama era, leading to documentation and discussions about the safety concerns. - The speakers claim that by the 2012 report and again by 2014, all vaccine samples from multiple countries contained residual DNA, and that Japan became a hub for disseminating awareness of these issues globally. They state that the issue was present not only in the early Gardasil (Gardasil-4) but also in later forms, with references to Gardasil-9 and the idea that the DNA contamination and adjuvant interactions could contribute to immune and neurological symptoms in recipients, particularly in women and girls. - They discuss changes to WHO and FDA guidelines on residual DNA limits, noting a progression from 10 picograms to higher thresholds over time, implying corporate interests in allowing higher residual DNA quantities in vaccines. They emphasize that the shift in limits is tied to pharmaceutical companies’ needs, not human biology changes, and argue that Japan highlighted the problem of Deinance-DNA contamination during the cervical cancer vaccine era, signaling that researchers, journalists, and victims were aware long before others. - Finally, Speaker 1 adds that two points became clear a year earlier: the disruption of messenger RNA–type vaccines as a response to safety concerns, and the subsequent rise in adverse outcomes after widespread vaccination, including deaths, which they claim intensified opposition to these vaccines. Note: The summary presents the speakers' claims and sequencing of events as described in the transcript without evaluation or endorsement.

The speaker, a viral immunologist, discusses the presence of bacterial plasma DNA in the Pfizer and Moderna COVID-19 vaccines. They explain that the DNA is not supposed to be there and that its presence indicates improper manufacturing. The speaker highlights the potential dangers of bacterial DNA, including its ability to activate the immune system and promote inflammation. They also suggest that the DNA could lead to prolonged expression of the spike protein and raise concerns about legal immunity for the manufacturers. The speaker calls for a worldwide moratorium on the technology until further research is conducted.

The speaker raises concerns about the contamination of current vaccines with DNA and the unknown consequences of this contamination. They argue that efforts should be made to eliminate DNA contamination, even if it means higher production costs. The speaker mentions a researcher from MIT who discovered that mRNA vaccines were contaminated with DNA, despite DNA not being listed as a component. They criticize the authorities for testing vaccines without DNA contamination on a small group of people, but then vaccinating billions of people with contaminated vaccines. The speaker highlights the potential risks of DNA contamination, including the possibility of cancer. They conclude by stating that vaccines from the second process should undergo more rigorous studies before being commercialized.

The speaker discusses the issue of DNA contamination in mRNA COVID-19 vaccines and questions the FDA's handling of the situation. They explain that normally rigorous tests are required for genotoxicity and immunogenesis, but the FDA seemed to ignore these requirements. The speaker also mentions that Moderna's own patent acknowledges the concerns related to DNA and insertional immunogenesis. They reveal that DNA fragments, including an antibiotic resistance gene and sequences from simian virus 40, were found in the vaccines. The speaker expresses concern about the potential risks associated with DNA damage, such as cancer and birth defects. They criticize the FDA for downplaying the issue and emphasize the importance of transparency.

The Pfizer vaccine is contaminated with plasma DNA, not just mRNA. This DNA is the DNA vector used as the template for the in vitro transcription reaction. This was discovered by sequencing vials of Pfizer vaccine from Colombia. It's surprising that there's any DNA in there. The speaker is alarmed about the possible consequences of this, including rare but serious side effects like death from cardiac arrest. Mixing DNA with a lipid complex allows it to enter cells and become a permanent fixture. This is a real hazard for genome modification of long-lived somatic cells, like stem cells, and could cause a sustained autoimmune attack. There is also a very real theoretical risk of future cancer in some people. The risk is not zero and it may be high enough that we ought to figure out if this is happening or not.

The speaker discusses the presence of DNA in the Pfizer vaccine and expresses concern about its potential consequences. They explain that they sequenced the DNA in the vaccine and found it surprising that any DNA was present. The speaker suggests that this DNA could be causing rare but serious side effects, such as death from cardiac arrest. They also mention that the DNA could integrate into the genomic DNA of cells, potentially leading to genome modification, autoimmune attacks, or even future cancer. The speaker acknowledges that these concerns are theoretical but believes they warrant further investigation.

The speaker discusses claims about modified RNA (MOD RNA) vaccines and DNA contamination in plasmids. They state that after creating MOD RNA on plasmids, the plasmid DNA remained and much of it could not be destroyed. They reference Kevin MacKurn’s discovery three years ago that vials were full of plasmid DNA, the whole plasmid and parts of it, and note that authorities allegedly minimized the issue, arguing that it doesn’t matter and that vaccines have saved millions of lives. The speaker asserts that the DNA in the vaccine vials was packaged in lipid nanoparticles and that this DNA would enter human cells. They reference colleagues’ publication last year (the INMODEO publication) showing that the DNA in the vaccine vials entered cells in culture and remained stable in cells for days, just as the MOD RNA did. Despite this, they say authorities dismissed the concerns with reassurance that nothing would happen. A pivotal point is attributed to a recent discovery by Kevin MacKinnon, claimed to be three weeks old, about what happens during transcription in the chromosome. The speaker explains that during production, byproducts occur and some mRNA strands do not detach from the DNA where they are formed, resulting in hybrids of DNA and RNA that come off together. The hybrids are described as dangerous, akin to “sparks of a sparkler,” and the speaker emphasizes that RNase H is an enzyme in the cell that takes care of these sparks and extinguishes them immediately. The speaker states that normal physicians don’t know about this, and they had to read up on RNase H after Jessica urged them to. The claimed consequence of failing to extinguish these hybrids is damage to the chromosome, with the metaphor that fires could light up and damage where they occur. The speaker asserts this could lead to “any illness that you see in the textbooks of medicine,” including tumors, neoplastic disease, autoimmune disease, developmental impairment, and death. They warn that the book of life—the genes and chromosomes—could be set on fire if these hybrids are not neutralized. The speaker says they have given interviews weekly, including one with Gary Null, and allege that this information is spreading worldwide. They claim that this situation is akin to attempted murder and exhort physicians globally not to participate, promising that those who do will be charged. They claim this issue is not limited to COVID vaccines but applies to all MOD RNA vaccines, including a flu MOD RNA vaccine now in use, and possibly veterinary vaccines, which they claim will be heavily contaminated with deadly dangerous hybrids. They urge authorities and controlling bodies to act, warning that they will face court if they fail to address the issue.